Literature DB >> 20385000

The realistic performance achievable with mycobacterial automated culture systems in high and low prevalence settings.

Sanne C van Kampen1, Richard M Anthony, Paul R Klatser.   

Abstract

BACKGROUND: Diagnostic tests are generally used in situations with similar pre-test probability of disease to where they were developed. When these tests are applied in situations with very different pre-test probabilities of disease, it is informative to model the likely implications of known characteristics of test performance in the new situation. This is the case for automated Mycobacterium tuberculosis (MTB) liquid culture systems for tuberculosis case detection which were developed and are widely used in low burden settings but are only beginning to be applied on a large scale in high burden settings.
METHODS: Here we model the performance of MTB liquid culture systems in high and low tuberculosis (TB) prevalence settings using detailed published data concentrating on the likely frequency of cross-contamination events.
RESULTS: Our model predicts that as the TB prevalence in the suspect population increases there is an exponential increase in the risk of MTB cross-contamination events expected in otherwise negative samples, even with equivalent technical performance of the laboratories. Quality control and strict cross-contamination measures become increasingly critical as the burden of MTB infection among TB suspects increases. Even under optimal conditions the realistically achievable specificity of these systems in high burden settings will likely be significantly below that obtained in low TB burden laboratories.
CONCLUSIONS: Liquid culture systems can play a valuable role in TB case detection in laboratories in high burden settings, but laboratory workers, policy makers and clinicians should be aware of the increased risks, independent of laboratory proficiency, of cross-contamination events in high burden settings.

Entities:  

Mesh:

Year:  2010        PMID: 20385000      PMCID: PMC2862026          DOI: 10.1186/1471-2334-10-93

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  10 in total

Review 1.  Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment.

Authors:  W J Burman; R R Reves
Journal:  Clin Infect Dis       Date:  2000-11-17       Impact factor: 9.079

2.  Impact of laboratory cross-contamination on molecular epidemiology studies of tuberculosis.

Authors:  Miguel Martínez; Darío García de Viedma; María Alonso; Sandra Andrés; Emilio Bouza; Teresa Cabezas; Isabel Cabeza; Armando Reyes; Waldo Sánchez-Yebra; Manuel Rodríguez; M Isabel Sánchez; M Cruz Rogado; Rosa Fernández; Teresa Peñafiel; Juan Martínez; Pilar Barroso; M Angeles Lucerna; L Felipe Diez; Carmelo Gutiérrez
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  The role of molecular epidemiology in low-income, high-burden countries.

Authors:  G D van der Spuy; R M Warren; P D van Helden
Journal:  Int J Tuberc Lung Dis       Date:  2009-04       Impact factor: 2.373

4.  Scaling up tuberculosis culture services: a precautionary note.

Authors:  R Urbanczik; H L Rieder
Journal:  Int J Tuberc Lung Dis       Date:  2009-07       Impact factor: 2.373

5.  Liquid culture for Mycobacterium tuberculosis: proceed, but with caution.

Authors:  R M Anthony; F G J Cobelens; A Gebhard; P R Klatser; R Lumb; S Rüsch-Gerdes; D van Soolingen
Journal:  Int J Tuberc Lung Dis       Date:  2009-09       Impact factor: 2.373

6.  Pseudo-outbreak of tuberculosis in an acute-care general hospital: epidemiology and clinical implications.

Authors:  W Cronin; E Rodriguez; S Valway; S Bur; N Hooper; R Smithwick; W R Butler; D Dwyer
Journal:  Infect Control Hosp Epidemiol       Date:  1998-05       Impact factor: 3.254

7.  Laboratory cross-contamination of Mycobacterium tuberculosis: an investigation and analysis of causes and consequences.

Authors:  M Poynten; D N Andresen; T Gottlieb
Journal:  Intern Med J       Date:  2002-11       Impact factor: 2.048

8.  False-positive mycobacterium tuberculosis cultures in 44 laboratories in The Netherlands (1993 to 2000): incidence, risk factors, and consequences.

Authors:  Annette S de Boer; Barbara Blommerde; Petra E W de Haas; Maruschka M G G Sebek; Kitty S B Lambregts-van Weezenbeek; Mirjam Dessens; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

9.  Reduction of the rate of false-positive cultures of Mycobacterium tuberculosis in a laboratory with a high culture positivity rate.

Authors:  Nora M Carroll; Madalene Richardson; Erica Engelke; Marianna de Kock; Carl Lombard; Paul D van Helden
Journal:  Clin Chem Lab Med       Date:  2002-09       Impact factor: 3.694

10.  The effect of changes in laboratory practices on the rate of false-positive cultures for Mycobacterium tuberculosis.

Authors:  P E Breese; W J Burman; M Hildred; B Stone; M L Wilson; Z Yang; M D Cave
Journal:  Arch Pathol Lab Med       Date:  2001-09       Impact factor: 5.534

  10 in total
  5 in total

1.  Dilemma of managing asymptomatic children referred with 'culture-confirmed' drug-resistant tuberculosis.

Authors:  Marian Loveday; Babu Sunkari; Ben J Marais; Iqbal Master; James C M Brust
Journal:  Arch Dis Child       Date:  2016-04-04       Impact factor: 3.791

2.  Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.

Authors:  Lesley E Scott; Kerrigan McCarthy; Natasha Gous; Matilda Nduna; Annelies Van Rie; Ian Sanne; Willem F Venter; Adrian Duse; Wendy Stevens
Journal:  PLoS Med       Date:  2011-07-26       Impact factor: 11.069

3.  Liquid vs Solid Culture Medium to Evaluate Proportion and Time to Change in Management of Suspects of Tuberculosis-A Pragmatic Randomized Trial in Secondary and Tertiary Health Care Units in Brazil.

Authors:  Adriana da Silva Rezende Moreira; Gisele Huf; Maria Armanda Monteiro da Silva Vieira; Paulo Albuquerque da Costa; Fábio Aguiar; Anna Grazia Marsico; Leila de Souza Fonseca; Mônica Ricks; Martha Maria Oliveira; Anne Detjen; Paula Isono Fujiwara; Stephen Bertel Squire; Afranio Lineu Kritski
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

4.  Comparison of Xpert MTB/RIF Assay and the Conventional Sputum Microscopy in Detecting Mycobacterium tuberculosis in Northern Thailand.

Authors:  Kanokwan Pinyopornpanish; Romanee Chaiwarith; Chansom Pantip; Rassamee Keawvichit; Kanlaya Wongworapat; Phadungkiat Khamnoi; Khuanchai Supparatpinyo; Thira Sirisanthana
Journal:  Tuberc Res Treat       Date:  2015-04-30

5.  GeneXpert MTB/RIF Testing in the Management of Patients with Active Tuberculosis; A Real Life Experience from Saudi Arabia.

Authors:  Ali S Omrani; Mohammed F Al-Otaibi; Souad M Al-Ateah; Fahad M Al-Onazi; Kamran Baig; Noura A El-Khizzi; Ali M Albarrak
Journal:  Infect Chemother       Date:  2014-03-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.